ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2019年11月13日 15時00分
Source:
Eisai
エーザイ、人事異動を発表
東京, 2019年11月13日 - (JCN Newswire) - エーザイ株式会社は本日、人事異動(2019年11月13日付)を以下のとおり発表しました。
2019年11月13日付 人事異動
■執行役員
新任務/旧任務/氏名
(出向)エーザイ・ファーマシューティカルズ・インディア・プライベート・リミテッド(EIL) EIL担当(執行役員)/APIソリューション事業部長(執行役員)/大石 哲也
■グローバル本社
新任務/旧任務/氏名
(出向)エーザイ・ファーマシューティカルズ・インディア・プライベート・リミテッド(EIL) EIL管理部長/エーザイデマンドチェーンシステムズ 戦略企画部 予算・原価管理グループ長/藤村 東
本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2019/news201982.html
概要:エーザイ株式会社
詳細はwww.eisai.co.jpをご覧ください。
Source: Eisai
セクター: バイオテック
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
MHI Group Issues its "SUSTAINABILITY DATABOOK 2024"
Dec 13, 2024 16:31 JST
Notification of Dissolution of Joint Management of LT Metal Co., Ltd. by TANAKA Kikinzoku Kogyo K.K. and LT Corp.
Dec 13, 2024 04:00 JST
MHI's Automated Picking Solution Utilizing Sigma Synx Fully Implemented at Kirin Group's Ebina Logistics Center, the First Such System in Japan
Dec 12, 2024 16:47 JST
NEC Announces Interim Results from Phase 1 Clinical Trial of NECVAX-NEO1, an AI-Driven Personalized Oral Cancer Vaccine, at ESMO Immuno-Oncology Congress 2024
Dec 12, 2024 16:27 JST
JCB, AEON Credit Service Indonesia, and Biznet, Indonesia's Leading Internet Provider, Launching AEON Biznet JCB Precious Card, Co-Brand Card
Dec 12, 2024 12:00 JST
JCB to Enable Seamless Transactions on ETA Applications for UK-Bound Travellers
Dec 12, 2024 12:00 JST
Fujitsu develops video analytics AI agent to support safe, secure, and efficient frontline workplaces
Dec 12, 2024 11:06 JST
Fujitsu develops world's first multi-AI agent security technology to protect against vulnerabilities and new threats
Dec 12, 2024 10:28 JST
Intelligent Joy Limited Signs MOU for Strategic Cooperation with First U.S. Capital Group
Dec 11, 2024 19:30 JST
Fujitsu concludes share transfer agreement concerning Fujitsu Communication Services Limited
Dec 11, 2024 16:36 JST
Eisai's "URECE(R)" (Dotinurad) Approved in China for Gout Patients with Hyperuricemia
Dec 11, 2024 14:45 JST
CELH Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Celsius Holdings, Inc. Investors of Securities Fraud Class Action Lawsuit Deadline
Dec 11, 2024 10:19 JST
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Wolfspeed, Inc.
Dec 11, 2024 10:15 JST
Combating customer harassment: Fujitsu, Toyo University and Kokoro Balance Research Institute launch field trial on AI-powered training program
Dec 11, 2024 10:11 JST
PACS Group, Inc. Investors: January 13, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Dec 11, 2024 10:10 JST
Acadia Healthcare Company, Inc. (ACHC) Investors: December 16, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Dec 11, 2024 10:05 JST
Provision of the First Template Function Adapted to the IFRS Sustainability Disclosure Standards in Japan (IFRS S1 and S2) on the Sustainable Finance Platform
Dec 10, 2024 19:16 JST
Fujitsu drives business process improvement at Mitsubishi Electric Engineering using SAP Signavio(R)
Dec 10, 2024 11:38 JST
HAIN Premieres December 13, Showcasing the Power of Turkish Cinema
Dec 09, 2024 23:00 JST
Fourteen new trains to drive first rail open access growth
Dec 09, 2024 20:10 JST
More Latest Release >>
Related Release
Eisai's "URECE(R)" (Dotinurad) Approved in China for Gout Patients with Hyperuricemia
12/11/2024 2:45:00 PM JST
"LEQEMBI" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico
12/5/2024 11:22:00 AM JST
LEQEMBI (Lecanemab) for the Treatment of Alzheimer's Disease Launched in South Korea
11/28/2024 4:26:00 PM JST
Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the "AD-DMT Registry" in Japan
11/26/2024 3:50:00 PM JST
Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
11/20/2024 11:51:00 AM JST
Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
11/20/2024 10:24:00 AM JST
Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)
11/15/2024 5:33:00 PM JST
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
11/15/2024 2:31:00 PM JST
Eisai's Corporate Venture Capital Subsidiary, Eisai Innovation, Inc., Selected for AMED's 'Strengthening Program for Pharmaceutical Startup Ecosystem"
11/5/2024 11:35:00 AM JST
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status
11/1/2024 1:56:00 PM JST
More Press release >>